Biomea Fusion (BMEA) vs Rallybio (RLYB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Rallybio (RLYB) has outperformed Biomea Fusion (BMEA) over the past year, gaining 277.9% versus a loss of 28.5%. Over five years, RLYB leads with a -86.4% price change compared with -88.7% for BMEA. Biomea Fusion is the larger company by market cap ($95.4 million vs $89.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BMEA | RLYB |
|---|---|---|
| Share price | $1.32 | $16.93 |
| Market cap | $95.44M | $89.94M |
| 1-day change | +5.60% | -0.88% |
| YTD return | +6.45% | +208.49% |
| 1-year return | -28.46% | +277.90% |
| 5-year return | -88.65% | -86.36% |
| P/E ratio (TTM) | — | 2.11 |
| EPS (TTM) | $-0.29 | $8.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.24 | $17.57 |
| 52-week low | $0.872 | $3.67 |
| Distance from 52-week high | -40.99% | -3.66% |
| Average volume | 1.47M | 22.16K |
| Shares outstanding | 72.30M | 5.31M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RLYB has outperformed BMEA by 306.4 percentage points over the past year.
BMEA vs RLYB FAQ
Which is bigger, Biomea Fusion or Rallybio?
Biomea Fusion (BMEA) is larger, with a market capitalization of $95.44M compared with $89.94M for Rallybio (RLYB).
Which stock has performed better over the past year, BMEA or RLYB?
RLYB returned +277.90% over the past 12 months, compared with -28.46% for BMEA (price return, excluding dividends). Past performance does not predict future results.
Are Biomea Fusion and Rallybio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.